145 followers
192 followers
Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma. #MCL https://t.co/0rtrqWtFQO
110 followers
Very promising response rates
643 followers
Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma. #MCL https://t.co/0rtrqWtFQO
Very promising response rates